Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 562.00
Bid: 560.00
Ask: 568.00
Change: 12.00 (2.18%)
Spread: 8.00 (1.429%)
Open: 560.00
High: 562.00
Low: 550.00
Prev. Close: 550.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Divestment of EM4

18 Mar 2024 14:36

RNS Number : 2868H
Gooch & Housego PLC
18 March 2024
 

 

18 March 2024

 

Gooch & Housego PLC

("G&H" or the "Company" or the "Group")

 

Divestment of EM4

 

Completion of an important milestone on the rationalisation of the Group's A&D product portfolio

 

 

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components and systems announces that it has sold its subsidiary EM4, LLC to EMFOUR Acquisition Co., LLC, a subsidiary of a US-based global technology company (the "Buyer") for a total consideration of up to $12.0m (£9.4m) (the "Disposal").

 

The EM4 business, located near Boston (MA), manufactures optoelectronic components and laser modules primarily for the US A&D market. The business also manufactured and supplied fused fibre couplers, but this product line has been excluded from the sale and transferred to the Group's Torquay facility.

 

The total consideration payable of up to $12.0m comprises an initial consideration of $5.25m (£4.1m) and deferred consideration of up to $6.75m (£5.3m). The initial consideration will be settled in cash subject to customary adjustments for working capital, cash and debt at completion. The deferred consideration, which is based upon the performance of the EM4 business in the period ending 30 September 2025, will be settled in cash. The net proceeds of the Disposal will be used to reduce the Group's borrowings.

 

In the Group's results for the year ended 30 September 2023, the elements of the EM4 business that are subject to the sale contributed £13.4m of revenue and delivered a loss before tax of £0.7m. Some of the Group's global function resources previously charged to the EM4 business will be redeployed following the Disposal to support the execution of the Group's strategy. At 31 January 2024, the book value of the gross assets of the business totalled £12.4m. The Disposal and its associated costs are expected to generate a non-underlying charge of circa £8.0m (cash effect circa £1.5m). The transaction is expected to be marginally accretive to underlying earnings for the year ending 30 September 2024.

Charlie Peppiatt, Chief Executive Officer of Gooch and Housego, commented:

"I am pleased to be able to report the completion of an important milestone on our journey to deliver sustainable margin growth for the Group. The divestment of EM4 is the result of a carefully considered and ongoing review of our A&D product portfolio."

"The Disposal supports the Group's consolidation of our A&D activities into areas where we can offer differentiated products to our customers and enable the Group to grow our optical systems business and maximise value creation from accretive optical systems solutions."

"I would like to thank the EM4 team in Boston for their contribution to G&H and wish them well for the future."

 

 

For further information please contact:

 

Charlie Peppiatt, Chief Executive Officer

Chris Jewell, Chief Financial Officer 

Gooch & Housego PLC

+44 (0) 1460 256440

 

Mark Court / Sophie Wills / Abigail Gilchrist

G&H@buchanan.uk.com

Buchanan

+44 (0) 20 7466 5000

 

Christopher Baird / David Anderson

Investec Bank plc

+44 (0) 20 7597 5970

 

 

Notes to editors

 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBSGDXSXBDGSI
Date   Source Headline
26th Aug 20221:00 pmRNSDirector/PDMR Shareholding
19th Aug 202212:24 pmRNSNotification of Major Holdings
19th Aug 202212:19 pmRNSNotification of Major Holdings
17th Aug 202212:00 pmRNSDirector/PDMR Shareholding
17th Aug 202211:57 amRNSDirector/PDMR Shareholding
17th Aug 202211:54 amRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSTrading Update and Directorate Changes
13th Jun 202212:58 pmRNSHolding(s) in Company
7th Jun 20227:00 amRNSInterim Results
23rd May 20224:41 pmRNSSecond Price Monitoring Extn
23rd May 20224:36 pmRNSPrice Monitoring Extension
11th May 20227:00 amRNSNotification of Half Year Results
5th Apr 20227:00 amRNSHalf Year Trading Update
23rd Feb 20221:11 pmRNSResult of AGM
23rd Feb 20227:00 amRNSAGM Trading Update
9th Feb 20224:35 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSGrant of LTIP Awards
12th Jan 202212:18 pmRNSHolding(s) in Company
30th Dec 20214:41 pmRNSSecond Price Monitoring Extn
30th Dec 20214:36 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSPosting of Annual Report and AGM Notice
30th Nov 20217:00 amRNSResults for the year ended 30 September 2021
17th Nov 20217:00 amRNSNotification of Full Year Results
25th Oct 20214:41 pmRNSSecond Price Monitoring Extn
25th Oct 20214:35 pmRNSPrice Monitoring Extension
5th Oct 20217:00 amRNSFull Year Trading Update
18th Aug 20217:00 amRNSDiversity Underpins Competitive Advantage
27th Jul 202112:20 pmRNSUpdate on 2021 AGM Resolutions
9th Jun 20213:58 pmRNSPosting of Interim Report
3rd Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSInterim Results
10th May 20217:00 amRNSNotification of Half Year Results
28th Apr 20213:20 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSHalf Year Trading Update
26th Mar 20217:00 amRNSGrant of SAYE Options
12th Mar 20217:00 amRNSAppointment of Non-Executive Director
11th Mar 20214:59 pmRNSPCA to the Chairman Share Purchase
24th Feb 20211:01 pmRNSResult of AGM
24th Feb 20217:00 amRNSAGM Trading Update
8th Feb 202110:20 amRNSHolding(s) in Company
22nd Jan 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:35 pmRNSPrice Monitoring Extension
7th Jan 202112:17 pmRNSGrant of LTIP Awards
23rd Dec 20207:00 amRNSLaunch of Satellite Laser Communication System
18th Dec 20207:00 amRNSPosting of Annual Report and AGM Notice
1st Dec 20207:00 amRNSPreliminary Results
16th Nov 20207:00 amRNSNotification of Full Year Results
6th Oct 20207:00 amRNSFull Year Trading Update
2nd Sep 20207:00 amRNSTrading Update
1st Sep 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.